
Indee Labs
Enabling T cell immunotherapy discovery, development and manufacturing
Berkeley, United States · Founded 2015 · $500K raised
- Headquarters
- Berkeley, California
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- indeelabs.com
- Total Funding
- $500K
- Last Round
- $500K Corporate RoundFeb 2026
- Rounds
- 2
About
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
Summary
Indee Labs is a Biotech company based in Berkeley, United States, founded in 2015. It has raised $500K in total across 2 rounds, most recently a $500K Corporate Round round in Feb 2026. Investors include Kstart.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company